Compare
cbdMD, Inc. vs Axil Brands, Inc. vs United Guardian Inc vs Solesence, Inc.
| Latest fiscal year | cbdMD, Inc. YCBD | Axil Brands, Inc. AXIL | United Guardian Inc UG | Solesence, Inc. SLSN |
|---|---|---|---|---|
| Year ended | 2025-09-30 | 2026-05-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $19.19M | $30.85M | $10.55M | $62.06M |
| Revenue growth (YoY) | -1.5% | +17.5% | -13.4% | +18.6% |
| Gross margin | 62.4% | 69.3% | 48.8% (computed) | 25.9% |
| Operating margin | -11.3% | 9.7% | 21.3% | 2.5% |
| Net margin | -10.6% | 8.8% | 20.0% | 2.9% |
| Net income | -$2.04M | $2.70M | $2.11M | $1.79M |
| EPS (Diluted) | -$1.09 | $0.33 | n/a | $0.02 |
| Operating cash flow | -$1.45M | -$9.6K | $1.97M | -$8.57M |
| Free cash flow | -$1.64M | -$89.0K | $1.91M | n/a |
| Cash & equivalents | $2.26M | $4.46M | $1.25M | $1.29M |
| Total assets | $10.42M | $17.96M | $13.11M | $50.05M |
| Total liabilities | $3.19M | $4.81M | $1.88M | n/a |
| Shareholders' equity | $7.23M | $13.14M | $11.23M | $17.63M |
| Return on year-end equity | -28.2% | 20.5% | 18.7% | 10.2% |
| Shares outstanding | 8.92M | 6.82M | 4.59M | 70.61M |
Revenue, most recent five fiscal years
| Fiscal year | cbdMD, Inc. | Axil Brands, Inc. | United Guardian Inc | Solesence, Inc. |
|---|---|---|---|---|
| Latest | $19.19M Ended 2025-09-30 | $30.85M Ended 2026-05-31 | $10.55M Ended 2025-12-31 | $62.06M Ended 2025-12-31 |
| 1 year earlier | $19.48M Ended 2024-09-30 | $26.26M Ended 2025-05-31 | $12.18M Ended 2024-12-31 | $52.35M Ended 2024-12-31 |
| 2 years earlier | $24.16M Ended 2023-09-30 | $27.50M Ended 2024-05-31 | $10.89M Ended 2023-12-31 | $37.30M Ended 2023-12-31 |
| 3 years earlier | $35.40M Ended 2022-09-30 | $23.52M Ended 2023-05-31 | $12.70M Ended 2022-12-31 | $37.32M Ended 2022-12-31 |
| 4 years earlier | $44.48M Ended 2021-09-30 | $2.34M Ended 2022-05-31 | $13.93M Ended 2021-12-31 | $29.48M Ended 2021-12-31 |